{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:35Z","timestamp":1772119535510,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"CCSG Grant","award":["P30 CA168524"],"award-info":[{"award-number":["P30 CA168524"]}]},{"name":"CCSG Grant","award":["P30 CA168524"],"award-info":[{"award-number":["P30 CA168524"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10552-024-01948-3","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T15:48:30Z","timestamp":1734364110000},"page":"409-420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utilization and outcomes of serial cervical cancer screening in a National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in a non-Medicaid expansion state"],"prefix":"10.1007","volume":"36","author":[{"given":"Rubina","family":"Ratnaparkhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hope","family":"Krebill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Javellana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Spoozak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megha","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh Pal","family":"Mudaranthakam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"1948_CR1","unstructured":"Breast and Cervical Cancer Mortality Prevention Act of 1990 (2023) Pub L 301-354. http:\/\/uscode.house.gov\/statutes\/pl\/101\/354.pdf Accessed 27 Feb 2023"},{"key":"1948_CR2","unstructured":"Breast and Cervical Cancer Mortality Prevention Act of 1990 (2023) Pub L No. 301-354. http:\/\/www.cdc.gov\/cancer\/nbccedp\/legislation\/law.htm. Accessed 4 Apr 2023"},{"issue":"1","key":"1948_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.43582","volume":"5","author":"R Suk","year":"2022","unstructured":"Suk R, Hong Y, Rajan SS, Xie Z, Zhu Y, Spencer JC (2022) Assessment of US Preventive Services Task Force Guideline-concordant cervical cancer screening rates and reasons for underscreening by age, race and ethnicity, sexual orientation, rurality, and insurance, 2005 to 2019. JAMA Netw Open 5(1):e2143582. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.43582","journal-title":"JAMA Netw Open"},{"key":"1948_CR4","unstructured":"Kaiser Family Foundation (2024) Status of State Medicaid expansion decisions: interactive map. https:\/\/www.kff.org\/medicaid\/issue-brief\/status-of-state-medicaid-expansion-decisions-interactive-map\/#:~:text=To%20date%2C%2041%20states%20(including,analysis%20of%20state%20expansion%20activity. Accessed 10 Mar 2024"},{"key":"1948_CR5","unstructured":"World Health Organization (2022) Cervical cancer fact sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer. Accessed 23 Sept 2022"},{"key":"1948_CR6","unstructured":"Kansas Health Matters (2022) Healthy people 2030 progress tracker. https:\/\/www.kansashealthmatters.org\/indicators\/index\/dashboard?alias=hp2030. Accessed 23 Sept 2022"},{"key":"1948_CR7","unstructured":"SEER Cancer Stat Facts: Cervical Cancer (2023) National Cancer Institute. https:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html Accessed 27 Feb 2023"},{"issue":"5","key":"1948_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10552-015-0524-5","volume":"26","author":"FK Tangka","year":"2015","unstructured":"Tangka FK, Howard DH, Royalty J et al (2015) Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997\u20132012. Cancer Causes Control 26(5):671\u2013686. https:\/\/doi.org\/10.1007\/s10552-015-0524-5","journal-title":"Cancer Causes Control"},{"key":"1948_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10552-020-01286-0","volume":"31","author":"F Tangka","year":"2020","unstructured":"Tangka F, Kenny K, Miller J et al (2020) The eligibility and reach of the national breast and cervical cancer early detection program after implementation of the affordable care act. Cancer Causes Control 31:473\u2013489. https:\/\/doi.org\/10.1007\/s10552-020-01286-0","journal-title":"Cancer Causes Control"},{"issue":"5 Suppl 1","key":"1948_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","volume":"17","author":"LS Massad","year":"2013","unstructured":"Massad LS, Einstein MH, Huh WK et al (2013) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 17(5 Suppl 1):S1\u2013S27. https:\/\/doi.org\/10.1097\/LGT.0b013e318287d329","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"1948_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","volume":"24","author":"RB Perkins","year":"2020","unstructured":"Perkins RB, Guido RS, Castle PE et al (2020) 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 24(2):102\u2013131. https:\/\/doi.org\/10.1097\/LGT.0000000000000525","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"1948_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","volume":"330","author":"RB Perkins","year":"2023","unstructured":"Perkins RB, Wentzensen N, Guido RS, Schiffman M (2023) Cervical cancer screening: a review. JAMA 330(6):547\u2013558. https:\/\/doi.org\/10.1001\/jama.2023.13174","journal-title":"JAMA"},{"issue":"5","key":"1948_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/AOG.0b013e3181b8fc88","volume":"114","author":"KF Trivers","year":"2009","unstructured":"Trivers KF, Benard VB, Eheman CR, Royalty JE, Ekwueme DU, Lawson HW (2009) Repeat pap testing and colposcopic biopsies in the underserved. Obstet Gynecol 114(5):1049\u20131056. https:\/\/doi.org\/10.1097\/AOG.0b013e3181b8fc88","journal-title":"Obstet Gynecol"},{"key":"1948_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106078","volume":"135","author":"SJ Bartley","year":"2020","unstructured":"Bartley SJ, Benard V, Tai E, Rockwell T, Kenney K, Richardson LC (2020) Are uninsured women in a national screening program having longer intervals between cervical cancer screening tests? Prev Med 135:106078. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106078","journal-title":"Prev Med"},{"issue":"16","key":"1948_CR15","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1002\/cncr.28821","volume":"120","author":"B Yancy","year":"2014","unstructured":"Yancy B, Royalty JE, Marroulis S, Mattingly C, Benard VB, DeGroff A (2014) Using data to effectively manage a national screening program. Cancer 120(16):2575\u20132583","journal-title":"Cancer"},{"issue":"4","key":"1948_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1089\/jwh.2019.7726","volume":"28","author":"FL Wong","year":"2019","unstructured":"Wong FL, Miller JW (2019) Centers for disease control and prevention\u2019s National Breast and Cervical Cancer Early Detection Program: increasing access to screening. J Womens Health 28(4):427\u2013431. https:\/\/doi.org\/10.1089\/jwh.2019.7726","journal-title":"J Womens Health"},{"key":"1948_CR17","unstructured":"Bauder M, Luery D, Szelepka S (2014) Small area estimation of health insurance coverage in 2010\u20132012. https:\/\/www.census.gov\/programs-surveys\/sahie.html"},{"issue":"5","key":"1948_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10552-015-0571-y","volume":"26","author":"LP Dalzell","year":"2015","unstructured":"Dalzell LP, Tangka FK, Powers DS et al (2015) Data sources for identifying low-income, uninsured populations: application to public health-National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control 26(5):699\u2013709. https:\/\/doi.org\/10.1007\/s10552-015-0571-y","journal-title":"Cancer Causes Control"},{"issue":"5","key":"1948_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10552-020-01286-0","volume":"31","author":"F Tangka","year":"2020","unstructured":"Tangka F, Kenny K, Miller J, Howard DH (2020) The eligibility and reach of the national breast and cervical cancer early detection program after implementation of the affordable care act. Cancer Causes Control 31(5):473\u2013489. https:\/\/doi.org\/10.1007\/s10552-020-01286-0","journal-title":"Cancer Causes Control"},{"key":"1948_CR20","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s10552-010-9536-3","volume":"21","author":"FKL Tangka","year":"2010","unstructured":"Tangka FKL, O\u2019Hara B, Gardner JG, Turner J, Royalty J et al (2010) Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004\u20132006. Cancer Causes Control 21:1081\u20131090","journal-title":"Cancer Causes Control"},{"key":"1948_CR21","unstructured":"Bureau of Labor Statistics (2019) Labor force statistics from the current population survey. Series Id: LNS11000000. https:\/\/www.bls.gov\/cps\/cpsatabs.htm"},{"key":"1948_CR22","unstructured":"WHO (2020) Global strategy to accelerate the elimination of cervical cancer as a public health problem. https:\/\/www.who.int\/publications-detail-redirect\/9789240014107. Accessed 3 Apr 2023"},{"issue":"16","key":"1948_CR23","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/cncr.28820","volume":"120","author":"NC Lee","year":"2014","unstructured":"Lee NC, Wong FL, Jamison PM, Jones SF, Galaska L, Brady KT, Wethers B, Stokes-Townsend GA (2014) Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning. Cancer 120(16):2540\u20132548. https:\/\/doi.org\/10.1002\/cncr.28820","journal-title":"Cancer"},{"issue":"26","key":"1948_CR24","first-page":"661","volume":"65","author":"LJ Viens","year":"2016","unstructured":"Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M, Centers for Disease Control and Prevention (CDC) (2016) Human papillomavirus\u2013associated cancers\u2014United States, 2008\u20132012. MMWR 65(26):661\u2013666","journal-title":"MMWR"},{"issue":"6","key":"1948_CR25","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/cncr.30507","volume":"123","author":"AL Beavis","year":"2017","unstructured":"Beavis AL, Gravitt PE, Rositch AF (2017) Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer 123(6):1044\u20131050","journal-title":"Cancer"},{"issue":"4","key":"1948_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/LGT.0000000000000435","volume":"22","author":"S Feldman","year":"2018","unstructured":"Feldman S, Cook E, Davis M et al (2018) Cervical cancer incidence among elderly women in Massachusetts compared with younger women. J Low Genit Tract Dis 22(4):314\u2013317","journal-title":"J Low Genit Tract Dis"},{"issue":"15","key":"1948_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.15585\/mmwr.mm6815a1","volume":"68","author":"NM McClung","year":"2019","unstructured":"McClung NM, Gargano JW, Park IU et al (2019) Estimated number of cases of high-grade cervical lesions diagnosed among women\u2014United States, 2008 and 2016. MMWR Morb Mortal Wkly Rep 68(15):337\u2013343","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1948_CR28","doi-asserted-by":"publisher","DOI":"10.7326\/M19-1182","author":"JF Laprise","year":"2019","unstructured":"Laprise JF, Chesson HW, Markowitz LE et al (2019) Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States. Ann Intern Med. https:\/\/doi.org\/10.7326\/M19-1182","journal-title":"Ann Intern Med"},{"key":"1948_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.105880","volume":"130","author":"DM Harper","year":"2020","unstructured":"Harper DM, Plegue M, Harmes KM et al (2020) Three large scale surveys highlight the complexity of cervical cancer under-screening among women 45\u201365 years of age in the United States. Prev Med 130:105880","journal-title":"Prev Med"},{"issue":"13","key":"1948_CR30","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/cncr.28548","volume":"120","author":"AF Rositch","year":"2014","unstructured":"Rositch AF, Nowak RG, Gravitt PE (2014) Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer 120(13):2032\u20132038","journal-title":"Cancer"},{"issue":"3","key":"1948_CR31","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/ijc.32826","volume":"147","author":"R Landy","year":"2020","unstructured":"Landy R, Sasieni PD, Mathews C, Wiggins CL, Robertson M, McDonald YJ, Goldberg DW, Scarinci IC, Cuzick J, Wheeler CM, New Mexico HPV Pap Registry Steering Committee (2020) Impact of screening on cervical cancer incidence: a population-based case-control study in the United States. Int J Cancer 147(3):887\u2013896. https:\/\/doi.org\/10.1002\/ijc.32826","journal-title":"Int J Cancer"},{"issue":"23","key":"1948_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2021.101415","volume":"29","author":"KD Hughes","year":"2021","unstructured":"Hughes KD, Haynes D, Joseph AM (2021) Novel mapping methods to describe utilization of free breast cancer screening from a state program. Prev Med Rep 29(23):101415. https:\/\/doi.org\/10.1016\/j.pmedr.2021.101415","journal-title":"Prev Med Rep"},{"issue":"5","key":"1948_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10552-015-0569-5","volume":"26","author":"S Subramanian","year":"2015","unstructured":"Subramanian S, Tangka FK, Ekwueme DU, Trogdon J, Crouse W, Royalty J (2015) Explaining variation across grantees in breast and cervical cancer screening proportions in the NBCCEDP. Cancer Causes Control 26(5):689\u2013695. https:\/\/doi.org\/10.1007\/s10552-015-0569-5","journal-title":"Cancer Causes Control"},{"issue":"8","key":"1948_CR34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10552-019-01190-2","volume":"30","author":"JG Trogdon","year":"2019","unstructured":"Trogdon JG, Ekwueme DU, Subramanian S, Miller JW, Wong FL (2019) The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs. Cancer Causes Control 30(8):813\u2013818. https:\/\/doi.org\/10.1007\/s10552-019-01190-2","journal-title":"Cancer Causes Control"},{"issue":"7","key":"1948_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1158\/1940-6207.CAPR-22-0531","volume":"16","author":"MS Rockwell","year":"2023","unstructured":"Rockwell MS, Armbruster SD, Capucao JC, Russell KB, Rockwell JA, Perkins KE, Huffstetler AN, Mafi JN, Fendrick AM (2023) Reallocating cervical cancer preventive service spending from low- to high-value clinical scenarios. Cancer Prev Res (Phila) 16(7):385\u2013391. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-22-0531","journal-title":"Cancer Prev Res (Phila)"},{"key":"1948_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106014","volume":"133","author":"A Goding Sauer","year":"2020","unstructured":"Goding Sauer A, Bandi P, Saslow D, Islami F, Jemal A, Fedewa SA (2020) Geographic and sociodemographic differences in cervical cancer screening modalities. Prev Med 133:106014. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106014","journal-title":"Prev Med"},{"key":"1948_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ygyno.2024.01.020","volume":"184","author":"VG Dorismond","year":"2024","unstructured":"Dorismond VG, Saraiya M, Gopalani SV, Soman A, Kenney K, Miller J, Sawaya GF (2024) Variation in cervical cancer screening test utilization and results in a United States-based program. Gynecol Oncol 184:96\u2013102. https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.020","journal-title":"Gynecol Oncol"},{"key":"1948_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106871","volume":"154","author":"JS Haas","year":"2022","unstructured":"Haas JS, Cheng D, Yu L, Atlas SJ, Clark C, Feldman S, Silver MI, Kamineni A, Chubak J, Pocobelli G, Tiro JA, Kobrin SC (2022) Variation in the receipt of human papilloma virus co-testing for cervical screening: individual, provider, facility and healthcare system characteristics. Prev Med 154:106871. https:\/\/doi.org\/10.1016\/j.ypmed.2021.106871","journal-title":"Prev Med"},{"issue":"6","key":"1948_CR39","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.mcna.2020.08.006","volume":"104","author":"TJ Eun","year":"2020","unstructured":"Eun TJ, Perkins RB (2020) Screening for cervical cancer. Med Clin North Am 104(6):1063\u20131078. https:\/\/doi.org\/10.1016\/j.mcna.2020.08.006","journal-title":"Med Clin North Am"},{"issue":"10","key":"1948_CR40","doi-asserted-by":"publisher","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","volume":"132","author":"K Nanda","year":"2000","unstructured":"Nanda K, McCrory DC, Myers ER et al (2000) Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 132(10):810\u2013819","journal-title":"Ann Intern Med"},{"issue":"7","key":"1948_CR41","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/oxfordjournals.aje.a117485","volume":"141","author":"MT Fahey","year":"1995","unstructured":"Fahey MT, Irwig L, Macaskill P (1995) Meta-analysis of Pap test accuracy. Am J Epidemiol 141(7):680\u2013689","journal-title":"Am J Epidemiol"},{"key":"1948_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx225","author":"M Schiffman","year":"2017","unstructured":"Schiffman M, Kinney WK, Cheung LC et al (2017) Relative performance of HPV and cytology components of cotesting in cervical screening. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djx225","journal-title":"J Natl Cancer Inst"},{"key":"1948_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju153","author":"JC Gage","year":"2014","unstructured":"Gage JC, Schiffman M, Katki HA et al (2014) Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju153","journal-title":"J Natl Cancer Inst"},{"key":"1948_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g130","volume":"348","author":"KM Elfstrom","year":"2014","unstructured":"Elfstrom KM, Smelov V, Johansson ALV et al (2014) Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial. BMJ 348:g130","journal-title":"BMJ"},{"issue":"7","key":"1948_CR45","doi-asserted-by":"publisher","first-page":"67486","DOI":"10.1001\/jama.2018.10897","volume":"320","author":"SJ Curry","year":"2018","unstructured":"US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK et al (2018) Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA 320(7):67486","journal-title":"JAMA"},{"issue":"3","key":"1948_CR46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.vaccine.2006.05.117","volume":"24","author":"M Arbyn","year":"2006","unstructured":"Arbyn M, Sasieni P, Meijer CJLM et al (2006) Chapter 9: clinical applications of HPV testing: a summary of meta-analyses. Vaccine 24(3):78\u201389","journal-title":"Vaccine"},{"issue":"5","key":"1948_CR47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ajcp\/aqy114","volume":"150","author":"RM Austin","year":"2018","unstructured":"Austin RM, Onisko A, Zhao C (2018) Enhanced detection of cervical cancer and precancer through use of imaged liquid-based cytology in routine cytology and HPV cotesting. Am J Clin Pathol 150(5):385\u2013392","journal-title":"Am J Clin Pathol"},{"key":"1948_CR48","unstructured":"Kim JJ, Burger EA, Regan C, et al (2018) Screening for cervical cancer in primary care: a decision analysis for the U.S. Preventive services task force. Agency for Health-care Research and Quality (US). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK525069\/. Accessed 9 Apr 2019"},{"issue":"25","key":"1948_CR49","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1200\/JCO.2011.38.8389","volume":"30","author":"PE Castle","year":"2012","unstructured":"Castle PE, Glass AG, Rush BB et al (2012) Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up. J Clin Oncol 30(25):3044\u20133050","journal-title":"J Clin Oncol"},{"issue":"1","key":"1948_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/M17-1609","volume":"168","author":"PE Castle","year":"2018","unstructured":"Castle PE, Kinney WK, Xue X et al (2018) Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical cancer: an observational cohort study. Ann Intern Med 168(1):20\u201329","journal-title":"Ann Intern Med"},{"key":"1948_CR51","unstructured":"American Cancer Society (2022) Cancer statistics center. https:\/\/cancerstatisticscenter.cancer.org\/#!\/state\/Kansas. Accessed 23 Sept 2022"},{"key":"1948_CR52","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21628","author":"ET Fontham","year":"2020","unstructured":"Fontham ET, Wolf AM, Church TR et al (2020) Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21628","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"1948_CR53","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","volume":"360","author":"R Sankaranarayanan","year":"2009","unstructured":"Sankaranarayanan R, Nene BM, Shastri SS et al (2009) HPV screening for cervical cancer in rural India. N Engl J Med 360(14):1385\u20131394","journal-title":"N Engl J Med"},{"issue":"16","key":"1948_CR54","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1056\/NEJMoa035419","volume":"349","author":"GF Sawaya","year":"2003","unstructured":"Sawaya GF, McConnell KJ, Kulasingam SL et al (2003) Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 349(16):1501\u20131509","journal-title":"N Engl J Med"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-024-01948-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-024-01948-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-024-01948-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:43:24Z","timestamp":1744191804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-024-01948-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1948"],"URL":"https:\/\/doi.org\/10.1007\/s10552-024-01948-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5089897\/v1","asserted-by":"object"}]},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The University of Kansas Medical Center Institutional Review Board (IRB) approved the study as the central IRB institutions (STUDY00149362).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The original study was approved as a quality improvement project, and the University of Kansas Medical Center Institutional Review Board waived the need for patient consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}